Industry News

Bayer Chemicals AG Expands Production in North America

Published on 2004-05-18. Author : SpecialChem


With immediate effect, Bayer Chemicals AG, Leverkusen, will take over the production of all the biocidal formulations based on thiabendazole (TBZ) and dibromodicyanobutane (DBDCB) that it acquired from Ondeo Nalco at the end of 2002, manufacturing them for the global market in Wellford, South Carolina, U.S.A.

These EPA (Environmental Protection Agency) approved biocides and their formulations, marketed under the proprietary names Tektamer™, Metasol™ and Biochek™, were previously still manufactured by Ondeo Nalco. Dr. Jens Lorentzen, Head of Marketing in the Material Protection Products Business Unit of Bayer Chemicals, says: "We have decided to take over the production of these products as well as their marketing to use the available technology basis more strongly for the development and market introduction of new customized formulations, in particular for the North American market. In addition, this step should help us to improve reliability of supply."

Bayer Chemicals invested some US$ 500,000 in the expansion of its production facilities for this purpose. The Tektamer™ DBDCB range comprises efficient in-can preservatives for combating bacteria, mold fungi and yeast and is the leading preservative range in the U.S.A. for the adhesives industry. Other important fields of application are mineral slurries, surface coatings, latices, printing inks, waxes and other waterborne industrial products such as household detergents.

The Biochek™ range is also produced in Wellford. This includes patent-protected formulations based on DBDCB and other active ingredients for in-can preservation.

The Metasol™ range comprises the fungicidal active ingredient TBZ in various supply forms for the protection of coatings, plastics and adhesives and paper and cardboard.

The toxicological and ecotoxicological properties of these active ingredients and their formulations have been broadly tested. The products have a beneficial profile, are efficient and safe in their use. According to Lorentzen, these globally registered products, which are already firmly established on the North American market, will in future be marketed more strongly in Europe and Asia too.

Forward-looking statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Chemicals AG management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future consolidated results, financial situation, development or performance of Bayer Chemicals AG or our parent company, Bayer AG, and the estimates given here. These factors include those discussed in Bayer AG's public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including Bayer AG's Form 20-F). Neither Bayer AG nor Bayer Chemicals AG assumes any liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Source: Bayer Chemicals AG

The Chemicals Sales & Marketing Toolbox
Channel Alerts

Receive weekly digests on hot topics

Back to Top